A detailed history of Jane Street Group, LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 17,021 shares of NVCT stock, worth $124,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,021
Holding current value
$124,253
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.98 - $8.25 $101,785 - $140,423
17,021 New
17,021 $107,000
Q1 2023

May 15, 2023

BUY
$7.32 - $14.37 $81,149 - $159,305
11,086 New
11,086 $145,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $107M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.